Nuclear Rel-A and c-Rel Protein Complexes Are Differentially Distributed Within Human Thymocytes

Journal of Immunology

Volumn 158, Issue 6, 1997, Pages 2585-2591

  Feuillard, Jean ^a,b   Dargemont, Catherine ^c   Ferreira, Valérie ^b   Tarantino, Nadine ^b   Debré, Patrice ^b   Raphael, Martine ^a,b   Körner, Marie ^b  

^a AVICENNE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA;

ANTIBODY SPECIFICITY; ARTICLE; CELL NUCLEUS; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE; THYMUS;

CELL NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; T-LYMPHOCYTES; THYMUS GLAND; TRANSCRIPTION FACTOR RELA;

EID: 0031569096     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
2. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
3. Kieran, M., V. Blank, F. Logeat, J. Vandekerckove, F. Lottspeich, O. Le Bail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and Israël A. 1990. The DNA binding sub-unit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007.
4. Mercurio, F., J. DiDonato, C. Rosette, and M. Karin. 1992. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705.
5. Finco, T. S., and A. S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263.
6. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1994. Differential interactions of Rel-NF-κB complexes with IκBa determine pools of constitutive and inducible NF-κB activity. EMBO J. 13:4608.
7. Grilli, M., J.-S. Chiu, and M. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
8. Bours, V., G. Franzoso, K. Brown, S. Park, V. Azarenko, Y. M. Tomita, K. Kelly, and U. Siebenlist. 1992. Lymphocyte activation and family of NF-κB transcription factor complexes. Curr. Top. Microbiol. Immunol. 182:411.
9. Fujita, T., G. P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by p50 and p65 subunits of NF-κB. Genes Dev. 6:775.
10. Sica, A., T.-H. Tan, N. R. Rice, M. Kretzschmar, P. Ghosh, and H. A. Young. 1992. The c-rel proto-oncogene product c-Rel but not NF-κB bind to the intronic region of the human interferon-γ gene at a site related to an interferon-stimulatable response element. Proc. Natl. Acad. Sci. USA 89:1740.
11. Brown, A. M., M. W. Linhoff, B. Stein, K. L. Wright, A. S. Baldwin, P. V. Basta, and P.-Y. Ting. 1994. Function of NF-κB binding sites in the major histocompatibility complex class II invariant chain promotor is dependent on cell-specific binding of different NF-κB/Rel subunits. Mol. Cell. Biol. 14:2926.
12. Perkins, N. D., R. M Schmid, C. S. Duckett, K. Leung, N. R. Rice, and G. J. Nabel. 1992. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA 89:1529.
13. Körner, M., N. Tarantino, and P. Debré. 1991. Constitutive activation of NF-κB in human thymocytes. Biochem. Biophys. Res. Commun. 181:80.
14. 2+-regulated kinases. Cytokine 3:257.
15. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248.
16. Garcia, J. A., F. K. Wu, R. Mitsuyasu, and R. B. Gaynor. 1987. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO. J. 6:3761.
17. Köner, M., A. Harel-Bellan, A. T Brini, and W. L. Farrar. 1990. Characterization of the human immunodeficiency virus type 1 enhancer-binding proteins from the human T-cell line Jurkat. Biochem. J. 265:547.
18. Rice, N. R., M. L. MacKichan, and A. Israel. 1992. The precursor of NF-κB has a IκB-like functions. Cell 71:243.
19. Hsu, S.-M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem. 29:577.
20. Cressman, D., and R. Taub. 1994. Physiologic turnover of nuclear factor κB by nuclear proteolysis. J. Biol. Chem. 269:26594.
21. Jameson, S. C., K. A. Hogquist, and M. J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93.
22. Carrasco, D., F. Weil, and R. Bravo. 1994. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development 120:2991.
23. Weil, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9:3289.
24. + T lymphocytes. Science 265:1452.
25. Carrasco, D., R.-P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221.
26. Weil, F., D. Carrasco, S. K. Durham, D. S. Barton, Ch. A. Rizzo, R.-P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331.
27. Burkly, L., C. Hession, L. Ogata, Ch. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531.
28. Nikolic-Zugic, J. 1991. Phenotypic and functional stages in the intrathymic development of αβ T cells. Immunol. Today 12:65.
29. Moore, N. C., J. Girdlestone, G. Anderson, J. J. T. Owen, and E. J. Jenkinson. 1995. Stimulation of thymocytes before and after positive selection results in the induction of different NF-κB/Rel protein complexes. J. Immunol. 155:4653.
30. Ivanov, V., and R. Ceredig. 1992. Transcription factors in mouse fetal thymus development. Int. Immunol. 4:729.
31. Ivanov, V., M. Merkenschlager, and R. Ceredig. 1993. Antioxidant treatment of thymic organ cultures decreases NF-κB and TCF1 (α) transcription factor activities and inhibits αβ T cell development. J. Immunol. 151:4694.
32. neg thymocytes resembles antigen-activated mature T cells. J. Exp. Med. 178:1139.
33. Sha, W. C., H.-Ch. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
34. Köntgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlington, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
35. Beg, A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167.